ZO® Medical Oclipse-C™ Broad-Spectrum Sunscreen SPF 50 Earns Skin Cancer Foundation Seal of Recommendation
IRVINE, Calif., Aug. 6, 2013 /PRNewswire/ -- ZO Skin Health, Inc. proudly announces that ZO® Medical Oclipse-C™ Broad-Spectrum Sunscreen SPF 50 has earned the illustrious Skin Cancer Foundation Seal of Recommendation.
With this appointment, Oclipse-C™ Broad-Spectrum Sunscreen SPF 50 joins the ranks of over eighty well-respected brands recommended by The Skin Cancer Foundation for their exceptional efficacy. Reviewed by an independent Photobiology Committee and granted only to products that have been proven to sufficiently and safely aid in the prevention of sun-induced damage to the skin, the Seal of Recommendation sets the consumer standard for trusted sun protection.
Oclipse-C™ Broad-Spectrum Sunscreen SPF 50 redefines broad-spectrum sun protection as the first professional sunscreen that not only provides UVA and UVB protection with 8% titanium dioxide, but also shields the skin from high energy visible (HEV) light. This innovative formulation goes beyond conventional UVA and UVB protection with the addition of fractionated melanin that minimizes the damaging effects of HEV light.
Clinical research has shown that damage from HEV light may be as harmful as that caused by UVA and UVB combined. Additionally, HEV light penetrates more deeply into the skin than UVA and UVB with the potential for greater long-term damage. The fractionated melanin found in Oclipse-C™ Broad-Spectrum Sunscreen SPF 50 interferes with HEV light absorption, helping to provide more complete protection than ever before.
Key benefits of the breakthrough formula include:
- Ultra-Mild: Supports daily use for even the most sensitive skin and post-procedure protection
- Fractionated Melanin: Shields the skin from harmful HEV light
- Robust Antioxidants: Defend against cell-damaging free radicals
- Effective Anti-Irritants: Inhibit the effect of cytokine interleukin to reduce redness
- Moisture Replenishment Complex: Supports natural replenishment of the skin moisture barrier
"We are honored to receive such a prestigious award that recognizes ZO Skin Health Inc.'s commitment to advancing the science of skincare, says ZO® creator and renowned dermatologist Zein Obagi, MD. "The foundation of any healthy skin routine is SPF protection, so we are always striving to discover innovative and advanced ways to prevent that initial damage from taking place."
Oclipse-C™ Broad-Spectrum Sunscreen SPF 50 is part of the ZO® Medical line, which includes therapeutic skin health solutions, prescription pharmaceuticals and new protocols created by Zein Obagi, MD, to achieve and optimize in-office results at home.
About ZO Skin Health, Inc.
ZO Skin Health, Inc. develops and delivers innovative skincare solutions that optimize skin health around the globe. Utilizing cutting-edge science and Dr. Zein Obagi's extensive clinical experience creating treatments and regimens for healthy skin, ZO Skin Health, Inc. provides comprehensive skincare programs for physicians and their patients. Committed to advancing effective treatments for healthy skin, ZO Skin Health, Inc. supports physicians' practices through skin health seminars and clinical training, and patients through a variety of educational programs. As a result, ZO Skin Health, Inc. is focused on providing products and protocols that bridge the gap between therapeutic treatments and daily care that allow patients to experience continuously healthy skin regardless of their age or unique skin condition. For more information, visit www.zoskinhealth.com.
About Zein Obagi, M.D.
Researcher, innovator, scientist, published author, lecturer and board-certified dermatologist, Dr. Zein Obagi has achieved international renown as a leading authority on skin rejuvenation. He is the ZO Skin Health, Inc. medical director and is responsible for the development of new skincare treatments, protocols and products to achieve healthy skin.
Over twenty years ago, Dr. Zein Obagi pioneered the concept of skin health and conceived of, and brought to market, a line of medical skincare products – the original Obagi Nu-Derm® System – that transformed aging skin. Dr. Obagi founded WorldWide Products, which produced and marketed the original Obagi Nu-Derm® System. At that time, Dr. Obagi merely intended to challenge the norms of traditional skin care. Instead he shattered the status quo. Today his ideas about skin health are no longer surprising; they have become mainstream. Subsequently WorldWide was purchased by Obagi Medical Products, Inc., a company with which Dr. Obagi no longer has any affiliation, but which retained his family name (Obagi®) as their trademark.
ZO Skin Health, Inc. and Dr. Obagi have no business relationship with Obagi Medical Products, and Obagi Medical Products does not sell or endorse using any ZO® product. "ZO" is a registered trademark of ZO Skin Health, Inc. "Obagi" and "Obagi Nu-Derm" are registered trademarks of Obagi Medical Products, Inc.
SOURCE ZO Skin Health, Inc.
More by this Source
Zein Obagi, M.D., To Reveal New Advances In Skin Heath Restoration, Rejuvenation, Treatments And New Guidelines On The Usage Of Hydroquinone, And The Introduction Of His Non-Hydroquinone Skin Brightening Protocol At ZO® Skin Health Seminar
Oct 01, 2013, 06:27 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.